Tevogen Bio showcased AI technology for T cell therapies at AI x Bio Philly

From GlobeNewswire: 2025-04-08 17:53:00

Tevogen presented at AI x Bio Philly, showcasing Tevogen.AI’s AI-driven technology for T cell therapies. The event brought together innovators in biotechnology and AI. Tevogen Bio is a clinical-stage immunotherapy company developing precision T cell therapies for infectious diseases and cancers. The company’s leadership emphasizes patient accessibility through advanced science and innovative business models. Tevogen has positive safety data from clinical trials and owns key intellectual property assets. The company is driven by experienced industry leaders and scientists. Forward-looking statements in the press release highlight Tevogen’s plans for expansion and development in the healthcare industry.



Read more at GlobeNewswire: Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x